Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Clinical trial NCT06793410 · RECRUITING

Trial details

NCT number: NCT06793410
Sponsor: Vastra Gotaland Region
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recipients of Allogeneic Stem Cell Transplantation HPV (Human Papillomavirus)-Associated Acute Myeloid Leukaemia Myelodysplastic Syndrome Diffuse Large B Cell Lymphoma (DLBCL)

Start date: 2025-05-12
Primary completion: 2029-10-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.